Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Oral testosterone therapy raises heart risk more than other methods.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The document concludes that more research is needed to fully understand the causes of PCOS.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Dutasteride is as safe for the heart as finasteride.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

Women with PCOS have a higher risk of heart disease.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.